Exploring the mast cell enigma: A personal reflection of what remains to be done

Experimental Dermatology

Volumn 17, Issue 2, 2008, Pages 91-99

  Henz, Beate M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Mast cell development; Mast cells; Mastocytosis; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CD2 ANTIGEN; CORTICOSTEROID; EOSINOPHIL CHEMOTACTIC FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICROSOMAL AMINOPEPTIDASE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PU 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

BACTERIAL IMMUNITY; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; COLD URTICARIA; DRUG HYPERSENSITIVITY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; LEUKEMOGENESIS; MAST CELL; MAST CELL LEUKEMIA; MASTOCYTOSIS; NONHUMAN; PARASITE IMMUNITY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; TUMOR IMMUNITY; URTICARIA; URTICARIA PIGMENTOSA; WOUND HEALING;

BACTERIAL INFECTIONS; CELL PROLIFERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN DISEASES, BACTERIAL; URTICARIA;

EID: 38349056846     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00658.x     Document Type: Review

References (99)

1. Ehrlich P. Beiträge zur Kenntnis der granulirten Bindegewebszellen und der eosinophilen Leukozyten. Arch Anat Physiol 1879: 3: 166-169.
2. Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki B M. Mast cells. Int J Dermatol 1995: 34: 1-10.
3. Bradding P, Okayama Y, Howarth P H, Church M K, Holgate S T. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995: 155: 297-307.
4. Wasserman S I, Goetzl E J, Austen K F. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol 1974: 112: 351-358.
5. Czarnetzki B M, König W, Lichtenstein L M. Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes. Inflammation 1976: 1: 201-215.
6. Czarnetzki B M, König W, Lichtenstein L M. Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis. Nature 1975: 258: 725-726.
7. Czarnetzki B M. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes. Immunobiology 1980: 157: 62-66.
8. Czarnetzki B M. Is eosinophil chemotactic factor identical with leukotriene B? Int Arch Allergy Appl Immunol 1982: 67: 181-183.
9. Fawcett D W. Cytological and pharmacological observations on the release of histamine by mast cells. J Exp Med 1954: 100: 217-224.
10. Czarnetzki B M, Hannich D, Niedorf H. In vitro studies on the development of rat peritoneal mast cells. Immunobiology 1979: 156: 470-476.
11. Czarnetzki B M, Figdor C G, Kolde G, Vroom T, Aalberse R, de Vries J E. Development of human connective tissue mast cells from purified blood monocytes. Immunology 1984: 51: 549-554.
12. Ginsburg H, Lagunoff D. The in vitro differentiation of mast cells: Cultures of cells from immunized mouse lymph nodes and thoracic duct lymph on fibroblast monolayers. J Cell Biol 1967: 35: 685-697.
13. Kitamura Y, Kasugai T, Arizono N, Matsuda H. Development of mast cells and basophils: Processes and regulation mechanisms. Am J Med Sci 1993: 306: 185-191.
14. Fodinger M, Fritsch G, Winkler K et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994: 84: 2954-2959.
15. Arinobu Y, Iwasaki H, Gurish M F et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005: 102: 18105-18110.
16. Rodewald H R, Dessing M, Dvorak A M, Galli S J. Identification of a committed precursor for the mast cell lineage. Science 1996: 271: 818-822.
17. Chen C C, Grimbaldeston M A, Tsai M, Weissman I L, Galli S J. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 2005: 102: 11129-11130.
18. Kirshenbaum A S, Goff J P, Semere T, Foster B, Scott L M, Metcalfe D D. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999: 94: 2333-2342.
19. Babina M, Schulke Y, Kirchhof L et al. The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci 2005: 62: 214-226.
20. Kitamura Y, Oboki K, Ito A. Molecular mechanisms of mast cell development. Immunol Allergy Clin North Am 2006: 26: 387-405.
21. Welker P, Grabbe J, Zuberbier T, Henz B M. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral mononuclear cells. J Invest Dermatol 2000: 114: 44-50.
22. Shimizu Y, Suga T, Maeno T et al. Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6. Clin Exp Allergy 2004: 34: 917-925.
23. Tachimoto H, Hudson S A, Bochner B S. Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation. J Allergy Clin Immunol 2001: 107: 302-309.
24. Krüger-Krasagakes S, Grützkau A, Baghramian R, Czarnetzki B M. Interactions of immature human mast cells with extracellular matrix: expression of specific integrin receptors and their role in cell adhesion to extracellular proteins. J Invest Dermatol 1996: 106: 538-543.
25. Gurish M F, Tao H, Abonia J P et al. Intestinal mast cell progenitors require CD49dβ7 (alpha4beta7 integrin) for tissue-specific homing. J Exp Med 2001: 194: 1243-1252.
26. Hartmann K, Henz B M, Krüger-Krasagakes S et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997: 89: 2863-2870.
27. Lippert U, Zachmann K, Henz B M, Neumann C. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular IL-8 chemokine receptors (CXCR1 and CXCR2). Exp Dermatol 2004: 13: 520-525.
28. Maurer M, Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 2005: 14: 923-929.
29. Czarnetzki B M, Krüger G, Sterry W. In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol 1983: 71: 161-167.
30. Kumamoto T, Shalhevet D, Matsue H et al. Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 2003: 102: 1654-1660.
31. Grabbe J, Welker P, Dippel E, Czarnetzki B M. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994: 287: 78-84.
32. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res 2006: 34: 97-115.
33. Metcalfe D D, Mekori J A, Rottem M. Mast cell ontogeny and apoptosis. Exp Dermatol 1995: 4: 227-230.
34. Czarnetzki B M, Grabbe J, Kolde G, Krüger-Krasagakes S, Zuberbier T. Mast cells in the cytokine network - the what, where from and what for. Exp Dermatol 1995: 4: 221-226.
35. Grabbe J, Welker P, Grützkau A et al. Induction of human leukemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor. Scand J Immunol 1998: 47: 324-331.
36. Welker P, Grabbe J, Czarnetzki B M. Human keratinocytes release mast cell differentiation factors other than SCF. Int Arch Allergy Appl Immunol 1995: 107: 139-141.
37. Welker P, Grabbe J, Grützkau A, Henz B M. Effects of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998: 94: 310-317.
38. Hu Z Q, Kobayashi K, Zenda N, Shimamura T. Tumor necrosis factor-alpha- and interleukin-6-triggered mast cell development from mouse spleen cells. Blood 1997: 89: 526-533.
39. Rottem M, Hull G, Metcalfe D D. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells. Exp Hematol 1994: 22: 1147-1155.
40. Royer B, Varadaradjalou S, Saas P et al. Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol 2001: 108: 80-86.
41. Thienemann F, Henz B M, Babina M. Regulation of mast cell characteristics by cytokines: Divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 2004: 296: 134-138.
42. Baccari G C, Raucci F, Di Fiore M M, Monteforte R. Induced maturation of frog mast cells by nerve growth factor during ontogenesis. Microsc Res Tech 2003: 62: 439-450.
43. Welker P, Grabbe J, Gibbs B, Henz B M. NGF induces mast cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000: 99: 418-426.
44. Lorentz A, Hoppe J, Worthmann H et al. Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells. Neurogastroenterol Motil 2007: 19: 301-308.
45. Gebhardt T, Sellge G, Lorentz A, Raab R, Manns M P, Bischoff SC. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. Eur J Immunol 2002: 32: 2308-2316.
46. Welker P, Grabbe J, Zuberbier T, Henz B M. IgE downmodulates SCF-driven mast cell development from cultured peripheral blood mononuclear cells. Int Arch Allergy Immunol 1999: 118: 292-293.
47. Kalesnikoff J, Huber M, Lam V et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001: 14: 801-811.
48. Grabbe J, Haas N, Czarnetzki B M. Die Mastzelle. Hautarzt 1994: 45: 55-64.
49. Valent P, Akin C, Sperr W R et al. Mastocytosis: Pathology, genetics, and current options for therapy. Leuk Lymphoma 2005: 46: 35-48.
50. Hartmann K, Henz B M. Mastocytosis: Recent advances in defining the disease. Br J Dermatol 2001: 144: 682-695.
51. Horny H P, Sotlar K, Valent P. Mastocytosis: State of the art. Pathobiology 2007: 74: 121-132.
52. Hartmann K, Henz B M. Classification of cutaneous mastocytosis: A modified consensus proposal. Leuk Res 2002: 26: 483-484.
53. Büttner C, Henz B M, Sepp N, Grabbe J. Identification of an activating c-kit mutation in adult but not in childhood onset indolent mastocytosis: A possible explanation for divergent clinical behavior. J Invest Dermatol 1998: 111: 1227-1231.
54. Yanagihori H, Oyama N, Nakamura K, Kaneko F. c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn 2005: 7: 252-257.
55. Garcia-Montero A C, Jara-Acevedo M, Teodosio C et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006: 108: 2366-2372.
56. Miettinen M, Lasota J. KIT (CD117). A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005: 13: 205-220.
57. Henz B M. SCF and c-kit in mastocytosis - a pandora's box holding more theories than proven facts. J Invest Dermatol 1998: 110: 186.
58. Hartmann K, Artuc M, Baldus S E et al. Enhanced expression of Bcl-2 and Bcl-x L in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol 2003: 163: 819-826.
59. Haas N, Hamann K, Grabbe J, Algermissen B, Czarnetzki B M. Phenotypic evaluation of skin lesions in urticaria pigmentosa and mastocytosis. Arch Dermatol Res 1994: 286: 380-385.
60. Hartmann K, Hermes B, Rappersberger K, Sepp N, Mekori Y A, Henz B M. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis. Br J Dermatol 2003: 149: 554-559.
61. Henz B M, Zuberbier T, Grabbe J, Monroe E, eds. Urticaria - Clinical, Diagnostic and Therapeutic Aspects. Berlin: Springer, 1998.
62. Zuberbier T, Bindslev-Jensen C, Canonica W et al. EAACI/GA 2 LEN guideline: Definition, classification, and diagnosis of urticaria. Allergy 2006: 61: 316-320.
63. Haas N, Birkle-Berlinger W, Henz B M. Prognosis of acute urticaria in children. Acta Derm Venereol 2005: 85: 74-75.
64. Zuberbier T, Iffländer J, Semmler C, Czarnetzki B M. Acute urticaria - clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996: 76: 295-297.
65. Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol 2007: 119: 752-754.
66. Czarnetzki B M, Breetholt K-H, Traupe H. Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol 1986: 15: 623-627.
67. Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Hide M. Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen. Arerugi 2007: 56: 54-57.
68. Zuberbier T, Pfrommer C, Specht K et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002: 109: 343-348.
69. Pfaar O, Klimek L. Eicosanoids, aspirin-intolerance and the upper airways - current standards and recent improvements of the desensitization therapy. J Physiol Pharmacol 2006: 57 (Suppl. 12): 5-13.
70. Bae J S, Kim S H, Ye Y M et al. Significant association of Fc€RIα promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007: 119: 449-456.
71. Hide M, Francis D M, Grattan C E, Hakimi J, Kochan J P, Greaves M W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993: 328: 1599-1604.
72. Marsland A M. Autoimmunity and complement in the pathogenesis of chronic urticaria. Curr Allergy Asthma Rep 2006: 6: 265-269.
73. Zuberbier T, Fiebiger E, Maurer D, Stingl G, Henz B M. Anti-Fc€RIα serum autoantibodies in different subtypes of urticaria. Allergy 2000: 55: 951-954.
74. Maurer M, Theoharides T, Granstein D et al. What is the physiological function of mast cells? Exp Dermatol 2003: 12: 886-910.
75. Metz M, Maurer M. Mast cells - key effector cells in immune responses. Trends Immunol 2007: 28: 234-241.
76. Dawicki W, Marshall J S. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007: 19: 31-38.
77. Furuta T, Kikuchi T, Iwakura Y, Watanabe N. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J Immunol 2006: 177: 3294-3302.
78. Maurer M, Lopez Kostka S, Siebenhaar F et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 2006: 20: 2460-2467.
79. Henz B M, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001: 10: 1-10.
80. Lu L F, Lind E F, Gondek D C et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006: 442: 997-1002.
81. Togawa M, Kiniwa M, Nagai H. The roles of IL-4, IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice. Life Sci 2001: 69: 699-705.
82. Yokozeki H, Wu M H, Sumi K et al. Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Clin Exp Immunol 2003: 132: 385-392.
83. Guhl S, Stefaniak R, Strathmann M et al. Bivalent effect of UV light on human skin mast cells - low level mediator release at baseline but potent suppression upon mast cell triggering. J Invest Dermatol 2005: 124: 453-456.
84. Townley S L, Grimbaldeston M A, Ferguson I et al. Nerve growth factor, neuropeptides, and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice. J Invest Dermatol 2002: 118: 396-401.
85. Rottem M, Mekori Y A. Mast cells and autoimmunity. Autoimmun Rev 2005: 4: 21-27.
86. Blank U, Essig M, Scandiuzzi L, Benhamou M, Kanamaru Y. Mast cells and inflammatory kidney disease. Immunol Rev 2007: 217: 79-95.
87. Rajput A B, Turbin D A, Cheang M C et al. Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: A study of 4,444 cases. Breast Cancer Res Treat 2007, in press.
88. Ch'ng S, Sullivan M, Yuan L, Davis P, Tan S T. Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma. Cancer Cell Int 2006: 6: 28.
89. Ozdemir O. Immunosurveillance function of human mast cell? World J Gastroenterol 2005: 11: 7054-7056.
90. Hermes B, Feldmann-Böddeker I, Welker P, Algermissen B, Grabbe J, Henz B M. Altered expression of mast cell tryptase and chymase and of c-kit in human cutaneous scar tissue. J Invest Dermatol 2000: 114: 51-55.
91. Artuc M, Steckelings U M, Henz B M. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002: 118: 391-395.
92. Weller K, Foitzik K, Paus R, Syska W, Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB J 2006: 20: 2366-2368.
93. Francis G S, Tang W H. Histamine, mast cells, and heart failure: Is there a connection? J Am Coll Cardiol 2006: 48: 1385-1386.
94. Shiota N, Rysa J, Kovanen P T, Ruskoaho H, Kokkonen J O, Lindstedt K A. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 2003: 21: 1935-1944.
95. Vasiadi M, Kempuraj D, Boucher W, Kalogeromitros D, Theoharides TC. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol 2006: 19: 787-794.
96. Narita S, Goldblum R M, Watson C S et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 2007: 115: 48-52.
97. Geoffrey R, Jia S, Kwitek A E et al. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol 2006: 177: 7275-7286.
98. Artuc M, Böhm M, Grützkau A, Zuberbier T, Luger T, Henz BM. Human mast cells in the neurohormonal network: Expression of POMC, detection of precursor proteases and evidence for IgE-dependent secretion of α-MSH. J Invest Dermatol 2006: 126: 1976-1981.
99. Slominski A T. Proopiomelanocortin signaling system is operating in mast cells. J Invest Dermatol 2006: 126: 1934-1936.